These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21714934)

  • 1. Periostin: a promising target of therapeutical intervention for prostate cancer.
    Sun C; Zhao X; Xu K; Gong J; Liu W; Ding W; Gou Y; Xia G; Ding Q
    J Transl Med; 2011 Jun; 9():99. PubMed ID: 21714934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
    Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
    Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsy.
    Sun C; Song C; Ma Z; Xu K; Zhang Y; Jin H; Tong S; Ding W; Xia G; Ding Q
    Proteome Sci; 2011 Apr; 9():22. PubMed ID: 21504578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of downregulation of prostate cancer antigen-1 expression on malignant biological behavior of prostate cancer LNCaP cells].
    Liu BQ; Wang YK; Wu YD; Wei JX; Li X
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):828-32. PubMed ID: 24447480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Silencing ERp29 promotes the invasiveness of human PCa cells in vitro: Molecular mechanisms].
    Zhu B; Huang ZC; Deng HH; Dong ZT; Zhao XK; Yang LY; Jiang HY
    Zhonghua Nan Ke Xue; 2020 Jul; 26(7):579-587. PubMed ID: 33377711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
    Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
    Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dishevelled-2 silencing reduces androgen-dependent prostate tumor cell proliferation and migration and expression of Wnt-3a and matrix metalloproteinases.
    Yang Y; Jiao L; Hou J; Xu C; Wang L; Yu Y; Li Y; Yang C; Wang X; Sun Y
    Mol Biol Rep; 2013 Jul; 40(7):4241-50. PubMed ID: 23652996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Differential Expression and Function of the Inflammatory Chemokine Receptor CXCR5 in Benign Prostatic Hyperplasia and Prostate Cancer.
    Yang L; Gao L; Chen Y; Tang Z; Zhu Y; Han P; Li X; Wei Q
    Int J Med Sci; 2015; 12(11):853-61. PubMed ID: 26640404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer.
    Ding M; Jiang CY; Zhang Y; Zhao J; Han BM; Xia SJ
    J Exp Clin Cancer Res; 2020 Feb; 39(1):28. PubMed ID: 32019578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
    Guo Z; Liu D; Su Z
    Tumour Biol; 2015 Jun; 36(6):4777-83. PubMed ID: 25636449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
    Chen W; Liu Y; Chen H; Ning H; Ding K
    Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Krüppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer.
    He HJ; Gu XF; Xu WH; Yang DJ; Wang XM; Su Y
    Acta Pharmacol Sin; 2013 Feb; 34(2):282-8. PubMed ID: 23023312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo.
    Liu R; Sun J; Zhang Z; Xu Y
    Cell Biol Int; 2012 Oct; 36(10):863-72. PubMed ID: 22612256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of endonuclease domain-containing 1 as a novel tumor suppressor in prostate cancer.
    Qiu J; Peng S; Si-Tu J; Hu C; Huang W; Mao Y; Qiu W; Li K; Wang D
    BMC Cancer; 2017 May; 17(1):360. PubMed ID: 28532481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG silencing induces apoptosis and suppresses proliferation, migration and invasion in LNCaP prostate cancer cells.
    Xu Y; Chen B; Zheng S; Wen Y; Xu A; Xu K; Li B; Liu C
    Cell Mol Biol Lett; 2016; 21():27. PubMed ID: 28536629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of periostin gene expression via RNA interference suppressed the proliferation, apoptosis and invasion in U2OS cells.
    Liu C; Huang SJ; Qin ZL
    Chin Med J (Engl); 2010 Dec; 123(24):3677-83. PubMed ID: 22166650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of MEOX1 Gene Inhibits Proliferation and Promotes Apoptosis of LNCaP Cells in Prostate Cancer.
    Zhu ZY; Wang XL; Li DP
    Cancer Biother Radiopharm; 2019 Mar; 34(2):91-102. PubMed ID: 30543460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma
    Kang X; Wang F; Lan X; Li X; Zheng S; Lv Z; Zhuang Y; Zhao Y; Zhou S
    Int J Med Sci; 2018; 15(1):69-76. PubMed ID: 29333089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.